Crandon A J, Peel K R, Anderson J A, Thompson V, McNicol G P
Br Med J. 1980 Aug 2;281(6236):345-7. doi: 10.1136/bmj.281.6236.345.
Administration of prophylactic low-dose subcutaneous heparin to prevent postoperative deep vein thrombosis is expensive, entails treating many patients unnecessarily, and causes some side effects. By using a predictive index a population of patients who are at particularly high risk of developing postoperative deep vein thrombosis may be identified preoperatively. Prophylaxis was given only to these patients, resulting in an incidence of deep vein thrombosis of 3.8% compared with 16.1% in previous studies in which no specific prophylaxis was given. By limiting prophylaxis to the group of patients identified by the predictive index as being at high risk of developing postoperative deep vein thrombosis results may be obtained that are as good as those expected from treating the whole population. Thus many patients are saved from exposure to low-dose subcutaneous heparin.
预防性使用小剂量皮下注射肝素以预防术后深静脉血栓形成成本高昂,会不必要地治疗许多患者,并会引发一些副作用。通过使用预测指标,可在术前识别出术后发生深静脉血栓形成风险特别高的患者群体。仅对这些患者进行预防,深静脉血栓形成的发生率为3.8%,而在之前未进行特殊预防的研究中这一发生率为16.1%。通过将预防措施局限于由预测指标确定为术后发生深静脉血栓形成高风险的患者群体,可获得与对全体患者进行治疗所预期的效果同样良好的结果。因此,许多患者得以避免接受小剂量皮下注射肝素治疗。